Drug Shortage Report for MYLAN-ATORVASTATIN

Last updated on 2018-10-24 History
Report ID 19456
Drug Identification Number 02392976
Brand name MYLAN-ATORVASTATIN
Common or Proper name ATORVASTATIN
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) ATORVASTATIN
Strength(s) 80MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 90BT, 500BT
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-10-20
Actual start date
Estimated end date 2018-10-26
Actual end date 2018-10-23
Shortage status Resolved
Updated date 2018-10-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v58 2018-09-20 French Compare
v57 2018-09-20 English Compare
v56 2018-09-19 English Compare
v55 2018-09-17 French Compare
v54 2018-09-17 English Compare
v53 2018-09-14 English Compare
v52 2018-09-13 French Compare
v51 2018-09-13 English Compare
v50 2018-09-13 French Compare
v49 2018-09-13 English Compare
v48 2018-09-12 English Compare
v47 2018-09-10 French Compare
v46 2018-09-10 English Compare
v45 2018-09-08 English Compare
v44 2018-09-06 French Compare
v43 2018-09-06 English Compare
v42 2018-09-06 English Compare
v41 2018-09-06 English Compare
v40 2018-09-04 French Compare
v39 2018-09-04 English Compare

Showing 21 to 40 of 78